Table 2 Risk factors affecting OS in patients with type 2 pRCC
From: TPX2 promotes papillary renal cell carcinoma progression by forming a ceRNA with LINC00894
Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | ||
Age | 75 | 0.987 (0.945—1.032) | 0.576 | ||
BMI | 75 | 1.009 (0.830—1.227) | 0.928 | ||
Sex | 75 | 0.348 | |||
Male | 55 | Reference | |||
Female | 20 | 0.512 (0.113—2.312) | 0.384 | ||
Fuhrman grading | 75 | 0.518 | |||
1 | 3 | 0.000 (0.000 - Inf) | 0.999 | ||
2 | 25 | 0.518 (0.137—1.955) | 0.332 | ||
3 | 42 | Reference | |||
4 | 5 | 1.560 (0.331—7.360) | 0.574 | ||
T.stage | 75 | 0.001 | |||
≥ T3a | 37 | Reference | Reference | ||
< T3a | 38 | 0.130 (0.029—0.590) | 0.008 | 1.162 (0.000—2783.886) | 0.970 |
N.stage | 75 | 0.005 | |||
N0 | 48 | Reference | Reference | ||
N1 | 27 | 5.106 (1.558—16.735) | 0.007 | 0.504 (0.069—3.663) | 0.498 |
M.stage | 75 | 0.003 | |||
M0 | 63 | Reference | Reference | ||
M1 | 12 | 7.135 (2.168—23.480) | 0.001 | 2.515 (0.297—21.273) | 0.397 |
Concomitant symptoms | 75 | 0.157 | |||
Yes | 37 | Reference | |||
No | 38 | 0.440 (0.135—1.435) | 0.174 | ||
Tumor thrombus | 75 | 0.001 | |||
Yes | 32 | Reference | Reference | ||
No | 43 | 0.129 (0.028—0.582) | 0.008 | 0.144 (0.000—426.529) | 0.634 |
Maximum diameter of tumor | 75 | 1.179 (1.072—1.297) | < 0.001 | 0.892 (0.720—1.105) | 0.295 |
Score | 75 | 1.061 (1.027—1.097) | < 0.001 | 1.072 (1.023—1.123) | 0.003 |